Johnson & Johnson’s (J&J) Tremfya (guselkumab) has been approved by the US Food and Drug Administration (FDA) to treat adults ...
Body mass index did not impact the safety and efficacy of etrasimod in patients with ulcerative colitis, according to 2 studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback